doi: 10.1016/j.biopsych.2016.05.023 304 YongYYYanLWangBDFanDSGuoMSYuLet al
Consequently, if patients seem to be non-responders to the drug prescribed in one or more of these clinical measures, clinicians should switch to other compounds
Semaglutide and other GLP-1 drugs produce gradual but sustained weight loss over 1620 weeks, with many patients continuing to lose weight for 52 weeks or longer
It belongs to a class of medications known as GLP-1 receptor agonists, which also includes Ozempic, Mounjaro, Zepbound, Trulicity, Rybelsus, Saxenda and Victoza
But theyre usually included as tier-4 (nonpreferred) drugs, which means they will require prior authorization for coverage and are not typically covered under standard benefit terms, according to Moore
While it doesn't address the underlying trigger, "by supporting cellular signalling, reducing inflammation and promoting scalp health, it can complement a treatment plan focused on correcting the root cause," says Gaboardi